Literature DB >> 17604439

Cutaneous and meningeal sporotrichosis in a HIV patient.

Raquel Vilela1, Guenael F Souza, Gláucia Fernandes Cota, Leonel Mendoza.   

Abstract

A male patient with HIV and past history of tuberculosis and suspected neurotoxoplasmosis was admitted to the hospital with vomiting and small nodules through all his body. Few of the nodules were found forming chains of enlarged lymphatic vessels, especially on lesions located on the limbs. Some of the nodules were ulcerated with a serosanguineous discharge. Collected samples from ulcerated and the nodular lesions showed the presence of Sporothrix schenckii in culture. Although all hemocultures were negative, a spinal fluid collected from this patient and cultures from the cutaneous lesions were both positive for S. schenckii. The patient showed improvement after treatment with Amphotericin B. Sadly, he later died of complications not related to the S. schenckii infection. This case of disseminated sporotrichosis is a remainder that in patients with immunological disorders exotic forms of this fungal clinical entity could be expected.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17604439     DOI: 10.1016/s1130-1406(07)70035-9

Source DB:  PubMed          Journal:  Rev Iberoam Micol        ISSN: 1130-1406            Impact factor:   1.044


  9 in total

1.  Immune response against Sporothrix schenckii in TLR-4-deficient mice.

Authors:  Micheli Fernanda Sassá; Lucas Souza Ferreira; Livia Carolina de Abreu Ribeiro; Iracilda Zeppone Carlos
Journal:  Mycopathologia       Date:  2012-07       Impact factor: 2.574

Review 2.  The impact of sporotrichosis in HIV-infected patients: a systematic review.

Authors:  José A S Moreira; Dayvison F S Freitas; Cristiane C Lamas
Journal:  Infection       Date:  2015-02-21       Impact factor: 3.553

Review 3.  Sporothrix schenckii and Sporotrichosis.

Authors:  Mônica Bastos de Lima Barros; Rodrigo de Almeida Paes; Armando Oliveira Schubach
Journal:  Clin Microbiol Rev       Date:  2011-10       Impact factor: 26.132

4.  Human sporotrichosis: recommendations from the Brazilian Society of Dermatology for the clinical, diagnostic and therapeutic management.

Authors:  Rosane Orofino-Costa; Dayvison Francis Saraiva Freitas; Andréa Reis Bernardes-Engemann; Anderson Messias Rodrigues; Carolina Talhari; Claudia Elise Ferraz; John Verrinder Veasey; Leonardo Quintella; Maria Silvia Laborne Alves de Sousa; Rodrigo Vettorato; Rodrigo de Almeida-Paes; Priscila Marques de Macedo
Journal:  An Bras Dermatol       Date:  2022-09-22       Impact factor: 2.113

5.  Growth conditions influence melanization of Brazilian clinical Sporothrix schenckii isolates.

Authors:  Rodrigo Almeida-Paes; Susana Frases; Paulo Cezar Fialho Monteiro; Maria Clara Gutierrez-Galhardo; Rosely Maria Zancopé-Oliveira; Joshua D Nosanchuk
Journal:  Microbes Infect       Date:  2009-03-27       Impact factor: 2.700

6.  Efficacy of posaconazole in murine experimental sporotrichosis.

Authors:  Fabiola Fernández-Silva; Javier Capilla; Emilio Mayayo; Josep Guarro
Journal:  Antimicrob Agents Chemother       Date:  2012-02-13       Impact factor: 5.191

7.  Sporothrix schenckii lymphadentitis in a male with X-linked chronic granulomatous disease.

Authors:  Jessica R Trotter; Panida Sriaroon; David Berman; Aleksandra Petrovic; Jennifer W Leiding
Journal:  J Clin Immunol       Date:  2013-11-16       Impact factor: 8.317

8.  Sporotrichosis: an update on epidemiology, etiopathogenesis, laboratory and clinical therapeutics.

Authors:  Rosane Orofino-Costa; Priscila Marques de Macedo; Anderson Messias Rodrigues; Andréa Reis Bernardes-Engemann
Journal:  An Bras Dermatol       Date:  2017 Sep-Oct       Impact factor: 1.896

9.  Phylogeography and evolutionary patterns in Sporothrix spanning more than 14 000 human and animal case reports.

Authors:  Y Zhang; F Hagen; B Stielow; A M Rodrigues; K Samerpitak; X Zhou; P Feng; L Yang; M Chen; S Deng; S Li; W Liao; R Li; F Li; J F Meis; J Guarro; M Teixeira; H S Al-Zahrani; Z Pires de Camargo; L Zhang; G S de Hoog
Journal:  Persoonia       Date:  2015-01-29       Impact factor: 11.051

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.